The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xenin.
In conclusion, these data demonstrate that TNP-470 increases plasma and intestinal xenin levels, and augments the antidiabetic advantages of sitagliptin.
PMID: 33279496 [PubMed - as supplied by publisher]
Source: Biochemical Pharmacology - Category: Drugs & Pharmacology Authors: Craig SL, Gault VA, Flatt PR, Irwin N Tags: Biochem Pharmacol Source Type: research
More News: Diabetes | Drugs & Pharmacology | Eating Disorders & Weight Management | Endocrinology | High Fat | Hormones | Incretin Therapy | Insulin | Januvia | Obesity | Pancreas | Respiratory Medicine | Study